Computer model offers more control over protein design
New approach generates a wider variety of protein sequences optimized to bind to drug targets.
New approach generates a wider variety of protein sequences optimized to bind to drug targets.
New MIT initiative delves into the biology of stem cells and cancer stem cells, seeks ways to identify, purify, and propagate them.
Lustgarten Foundation names MIT laboratory to improve understanding and treatment of a deadly disease
Awards emphasize cross-disciplinary training, support research to measure and model microbial communities and their influence on ocean processes.
Living and working in a glass cube, an interdisciplinary team of students reimagined the ambulance of the future as part of a global startup competition.
Natural killer cells’ failure to respond to infection may explain why the disease is more grave in some patients.
Metal cluster in enzyme that breaks down carbon dioxide can switch between two different shapes.
MIT.nano building, the largest of its kind, will usher in a new age of nanoscale advancements.
New faculty join the departments of Biology, Brain and Cognitive Sciences, Chemistry, Physics, Mathematics, and Earth, Atmospheric and Planetary Sciences.
Researchers identify an essential protein that helps enzymes relax overtwisted DNA so each strand can be copied during cell division.
PhD student Zijay Tang is developing a living material that can sense and filter water contaminants.
Research team shows the power of proteomics to discover new drug targets and help develop therapeutic strategies with fewer long-term side effects.
Three MIT postdocs earn competitive Howard Hughes Medical Institute fellowships that support diversity in the sciences.
Matthew Vander Heiden seeks new cancer treatments that exploit tumor cells’ abnormal metabolism.
By making hydrophobic sections water-soluble, researchers hope to learn more about protein structures.